Delivery of recombinant adeno-associated virus vectors to rat diaphragm muscle via direct intramuscular injection

Human Gene Therapy Methods

Volumn 24, Issue 6, 2013, Pages 364-371

  Smuder, Ashley J ^a   Falk, Darin J ^b   Sollanek, Kurt J ^a   Nelson, W Bradley ^a   Powers, Scott K ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG ADMINISTRATION ROUTE; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; MUSCLE CONTRACTION; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM; WEIGHT GAIN; WESTERN BLOTTING;

ANIMALS; DEPENDOVIRUS; DIAPHRAGM; FEMALE; GENES, REPORTER; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAMUSCULAR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890361470     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2013.055     Document Type: Article

References (43)

1. Aihara, H., and Miyazaki, J. (1998). Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867-870
2. Bish, L.T., Sleeper, M.M., et al. (2008). Percutaneous transendocardial delivery of self-complementary adeno-Associated virus 6 achieves global cardiac gene transfer in canines. Mol. Ther. 16, 1953-1959
3. Boriek, A.M., Rodarte, J.R., et al. (2001). Shape and tension distribution of the passive rat diaphragm. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R33-R41
4. Bowles, D.E., McPhee, S.W., et al. (2012). Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol. Ther. 20, 443-455
5. Byrne, B.J., Falk, D.J., et al. (2011). Pompe disease gene therapy. Hum. Mol. Genet. 20, R61-R68
6. Clark, K.R., Sferra, T.J., et al. (1997). Recombinant adeno-Associated viral vectors mediate long-Term transgene expression in muscle. Hum. Gene Ther. 8, 659-669
7. Davis, H.L., Michel, M.L., et al. (1995). Use of plasmid DNA for direct gene transfer and immunization. Ann. NY Acad. Sci. 772, 21-29
8. Falk, D.J., Mah, C.S., et al. (2013). Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Mol. Ther. 21, 1661-1667
9. Fisher, K.J., Jooss, K., et al. (1997). Recombinant adeno-Associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312
10. Gaj, T., Gersbach, C.A., et al. (2013). ZFN, TALEN, and CRISPR/ Cas-based methods for genome engineering. Trends Biotechnol. 31, 397-405
11. Gregorevic, P., Blankinship, M.J., et al. (2004). Systemic delivery of genes to striated muscles using adeno-Associated viral vectors. Nat. Med. 10, 828-834
12. Gregorevic, P., Blankinship, M.J., et al. (2008). Systemic microdystrophin gene delivery improves skeletalmuscle structure and function in old dystrophic mdx mice. Mol. Ther. 16, 657-664
13. Grose, W.E., Clark, K.R., et al. (2012). Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer. PLoS One 7, e39233
14. Hussain, S.N. (1998). Respiratory muscle dysfunction in sepsis. Mol. Cell Biochem. 179, 125-134
15. Inagaki, K., Fuess, S., et al. (2006). Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45-53
16. Kessler, P.D., Podsakoff, G.M., et al. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082-14087
17. Khan, I.F., Hirata, R.K., et al. (2011). AAV-mediated gene targeting methods for human cells. Nat. Protoc. 6, 482-501
18. Kornegay, J.N., Li, J., et al. (2010). Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol. Ther. 18, 1501-1508
19. Mah, C., Fraites, T.J., Jr., et al. (2004). A new method for recombinant adeno-Associated virus vector delivery to murine diaphragm. Mol. Ther. 9, 458-463
20. Mah, C.S., Falk, D.J., et al. (2010). Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. Mol. Ther. 18, 502-510
21. Matecki, S.,Dudley, R.W., et al. (2004). Therapeutic gene transfer to dystrophic diaphragmby an adenoviral vector deleted of all viral genes. Am. J. Physiol. Lung Cell Mol. Physiol. 287, L569-L576
22. McClung, J.M., Kavazis, A.N., et al. (2007). Caspase-3 regulation of diaphragm myonuclear domain during mechanical ventilationinduced atrophy. Am. J. Respir. Crit. Care Med. 175, 150-159
23. McCool, F.D., and Tzelepis, G.E. (2012). Dysfunction of the diaphragm. N. Engl. J. Med. 366, 932-942
24. Mendell, J.R., Rodino-Klapac, L.R., et al. (2009). Limb-girdle muscular dystrophy type 2D gene therapy restores alphasarcoglycan and associated proteins. Ann. Neurol. 66, 290-297
25. Mendell, J.R., Rodino-Klapac, L.R., et al. (2010). Sustained alphasarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Ann. Neurol. 68, 629-638
26. Mir, L.M., Bureau, M.F., et al. (1998). Long-Term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C. R. Acad. Sci. III 321, 893-899
27. Mizuno, M. (1991). Human respiratory muscles: Fibre morphology and capillary supply. Eur. Respir. J. 4, 587-601
28. Muzyczka, N. (1992). Use of adeno-Associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129
29. Pacak, C.A., and Byrne, B.J. (2011). AAV vectors for cardiac gene transfer: Experimental tools and clinical opportunities. Mol. Ther. 19, 1582-1590
30. Pacak, C.A.,Mah, C.S., et al. (2006). Recombinant adeno-Associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3-e9
31. Poole, D.C., Sexton, W.L., et al. (1997). Diaphragm structure and function in health and disease. Med. Sci. Sports Exerc. 29, 738-754
32. Powers, S.K., Demirel, H.A., et al. (1997). Myosin phenotype and bioenergetic characteristics of rat respiratory muscles. Med. Sci. Sports Exerc. 29, 1573-1579
33. Powers, S.K., Kavazis, A.N., et al. (2009). Prolonged mechanical ventilation alters diaphragmatic structure and function. Crit. Care Med. 37, S347-S353
34. Powers, S.K., Hudson, M.B., et al. (2011). Mitochondria-Targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness. Crit. Care Med. 39, 1749-1759
35. Reid, M.B. (2008). Free radicals and muscle fatigue: Of ROS, canaries, and the IOC. Free Radic. Biol. Med. 44, 169-179
36. Ruegg, M.A., and Glass, D.J. (2011). Molecular mechanisms and treatment options for muscle wasting diseases. Annu. Rev. Pharmacol. Toxicol. 51, 373-395
37. Segal, S.S., White, T.P., et al. (1986). Architecture, composition, and contractile properties of rat soleus muscle grafts. Am. J. Physiol. 250, C474-C479
38. Smith, B.K., Collins, S.W., et al. (2013). Phase I/II trial of adenoassociated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: Initial safety and ventilatory outcomes. Hum. Gene Ther. 24, 630-640
39. Sun, B., Young, S.P., et al. (2008). Correction of multiple striated muscles in murine Pompe disease through adeno-Associated virus-mediated gene therapy. Mol. Ther. 16, 1366-1371
40. Wang, B., Li, J., et al. (2009). Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin- deficient mice. J. Orthop. Res. 27, 421-426
41. Yu, C.Y., Yuan, Z., et al. (2009). A muscle-Targeting peptide displayed on AAV2 improves muscle tropism on systemic delivery. Gene Ther. 16, 953-962
42. Yue, Y., Ghosh, A., et al. (2008). A single intravenous injection of adeno-Associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol. Ther. 16, 1944-1952
43. Zolotukhin, S., Potter, M., et al. (2002). Production and purification of serotype 1, 2, and 5 recombinant adeno-Associated viral vectors. Methods 28, 158-167